Cargando…
Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
BACKGROUND: Pharmaceutical companies spent $57.5 billion on pharmaceutical promotion in the United States in 2004. The industry claims that promotion provides scientific and educational information to physicians. While some evidence indicates that promotion may adversely influence prescribing, physi...
Autores principales: | Spurling, Geoffrey K., Mansfield, Peter R., Montgomery, Brett D., Lexchin, Joel, Doust, Jenny, Othman, Noordin, Vitry, Agnes I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957394/ https://www.ncbi.nlm.nih.gov/pubmed/20976098 http://dx.doi.org/10.1371/journal.pmed.1000352 |
Ejemplares similares
-
Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic Review
por: Othman, Noordin, et al.
Publicado: (2009) -
Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study
por: Montgomery, Brett D, et al.
Publicado: (2008) -
Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis
por: Lexchin, Joel
Publicado: (2018) -
Donations Made and Received: A Study of Disclosure Practices of Pharmaceutical Companies and Patient Groups in Canada
por: Lexchin, Joel
Publicado: (2021) -
Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia
por: Othman, Noordin, et al.
Publicado: (2010)